GE Aerospace (GE)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-07
Reading GE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GE free→NYSEIndustrialsAerospace & DefenseSnapshot 2026-07-07
Reading GE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GE free→QuarterlyIQ Insights · GE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $366.94. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $367 the market pays 54× p/e — above the 38× p/e peer median but in line with its own 48× history. That premium reflects a durable franchise our peer-anchored $278 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts target $355–$455. Note: our $278 fair value sits below the entire analyst range ($355–$455). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Not investment advice.
$355.00 – $455.00 (median $370.00) · 4 analysts · as of 2026-07-02
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 187% over what the business is worth with no growth; closing that gap needs roughly 97.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $8.51/sh owner earnings.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $370.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $177.85 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $175.67 | — | — | Hist. CAGR | high |
| graham number | 12M | $51.35 | — | — | TTM | high |
| Mgmt guidance | 12M | $201.29 | 38.2 | 5.28 | Mgmt | high |
| Peer EV/EBITDA | 12M | $238.77 | 25.5 | 9.69 | TTM | high |
| Peer P/FCF | 12M | $241.80 | 34.2 | 7.07 | TTM | high |
| Peer P/E | 12M | $257.58 | 38.2 | 6.75 | TTM | high |
| Peer P/S | 12M | $152.91 | 3.3 | 45.84 | TTM | high |
| PEG | 12M | $253.46 | 37.5 | 6.75 | TTM | high |
| Own P/E history | 12M | $326.96 | 48.4 | 6.75 | TTM | high |
| triangulated | 12M | $277.98 | 38.2 | 7.28 | Triangulated | high |
| Mgmt guidance | 3Y | $393.01 | 38.2 | 10.30 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $367.75 | 34.2 | 10.76 | Hist. CAGR(prov.) | medium |
| Mgmt guidance | 5Y | $613.93 | 38.2 | 16.09 | Mgmt(prov.) | medium |
| Peer P/FCF | 5Y | $486.35 | 34.2 | 14.23 | Hist. CAGR(prov.) | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.